Strides Pharma Science informs about company update

06 Apr 2024 Evaluate
Strides Pharma Science has informed that a routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Formulations Facility of Strides Alathur, a wholly owned subsidiary of the Company, at Alathur, Chennai during the week of April 1, 2024 to April 5, 2024. The inspection closed with two observations. Company will respond to these observations comprehensively to FDA within the stipulated time. They will keep the stock exchanges informed if there is any further update in this matter.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

903.65 23.10 (2.62%)
18-Feb-2026 10:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.40
Dr. Reddys Lab 1282.65
Cipla 1342.00
Zydus Lifesciences 901.60
Lupin 2246.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×